Europe Radiotherapy Market, By Product & Services (Services, Product, and Software), Type (External-Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiotherapy/ Radiopharmaceuticals, and Others), Application (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, Spine Cancer, and Others), End User (Hospitals, Radiation Therapy Centers, Specialty Clinics, and Others), Distribution Channel (Direct Tenders, Third Party Distributors, and Others) - Industry Trends and Forecast to 2030.
Europe Radiotherapy Market Analysis and Size
The Europe incidence of cancer was on the rise, and radiotherapy is a crucial treatment modality for many cancer types. As the population continues to age and lifestyles change, the number of cancer cases was expected to increase, driving demand for radiotherapy. Increased awareness about cancer and its treatment options, along with improved screening and early detection methods, led to more individuals seeking cancer treatments, including radiotherapy. In many countries, healthcare spending has been increasing, providing more funding for advanced treatments like radiotherapy. Governments and private healthcare providers have been investing in upgrading their facilities and equipment.
Data Bridge Market Research analyzes that the radiotherapy market is expected to reach the value of USD 3,890.91 million by 2030, from USD 2,176.99 million in 2022, growing at a CAGR of 7.9% during the forecast period.
2023 to 2030
2021 (Customizable to 2015 - 2020)
Revenue in USD Million
Product & Services (Services, Product, and Software), Type (External-Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiotherapy/ Radiopharmaceuticals, and Others), Application (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, Spine Cancer, and Others), End User (Hospitals, Radiation Therapy Centers, Specialty Clinics, and Others), Distribution Channel (Direct Tenders, Third Party Distributors, and Others)
Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Sweden, and Rest of Europe
Market Players Covered
Siemens Healthcare GmbH, Elekta, Accuray Incorporated, General Electric Company, IBA Worldwide, Koninklijke Philips N.V., Hitachi, Ltd. , CANON MEDICAL SYSTEMS CORPORATION, Nordion Inc. (A Subsidiary of Sotera Health), Mevion Medical Systems, Eckert & Ziegler BEBIG, VIEWRAY TECHNOLOGIES, INC. (“VIEWRAY”), Brainlab, ZEISS International, BEBIG Medical., SHINVA MEDICAL INSTRUMENT CO., LTD., LinaTech, Inc., and United Imaging Healthcare Co., Ltd., among others
Radiotherapy is a type of treatment procedure that is mainly used for the treatment of cancer disease by the usage of X-rays along with similar forms of radiation technology. In radiotherapy treatment, high-energy-based radiation rays are often used to damage cancer cells and stop them from growing and dividing. Various types of software such as treatment planning software, dosage planning software, patient positioning software, image guiding software, and systemic radiotherapy among others are used in radiotherapy treatment planning. The treatment software program is used to calculate the dose of radiation which will be delivered to the patient's tumor and the surrounding normal tissue.
Europe Radiotherapy Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail below:
- Growing prevalence of cancer disease
The Europe incidence of cancer continues to rise due to factors such as aging populations, lifestyle changes, environmental factors, and increased cancer awareness and screening. The demand for effective treatment options such as radiotherapy grows as more individuals are diagnosed with cancer. Radiotherapy can be used as a primary treatment for cancer, especially in cases where surgery is not feasible or as effective. It can also be used in conjunction with surgery, chemotherapy, or immunotherapy to enhance treatment outcomes. The versatility of radiotherapy makes it an essential tool in the comprehensive cancer treatment arsenal.
Statistics on cancer describe that large groups of people have cancer across the world. Statistics show things that many people died from cancer each year. The treatment of radiotherapy can cure cancer symptoms. Radiation therapy uses high-energy particles or waves to kill the symptoms of cancer. Several people who are currently living with cancer require radiotherapy for cancer treatment. For this reason, the growing prevalence of cancer disease is acting as a driver for increasing the demand for the market.
- Novel technology in radiotherapy for cancer treatment
During the past several years, cancer radiotherapy has been largely driven by technological development. The technological development in radiotherapy is mainly focused on improving therapy procedures and launching new products which have advanced features that help in the treatment of cancer patients. This special issue aims at novel technological developments and has large potential in improving patient safety and treatment outcome in the radiotherapy management of cancers worldwide.
The modern and advanced technology-based radiotherapy procedure comprises the use of three-dimensional (3D) imaging technology, high-energy x-ray machines, and computerized treatment planning, which enhances the chances for more precise treatment possible. The increasing number of patients who successfully use radiation therapy due to technological advancement in radiotherapy and novel technology in radiotherapy for cancer treatment is expected to drive market growth.
- Increasing healthcare expenditure for cancer treatment
The government is continuously engaged in the activity of improving healthcare facilities to provide better health facilities and treatment to the patients such as improving cancer treatment procedures and increasing the number of radiotherapy treatment providers, among others. Growing healthcare expenditure is an opportunity for the market, because if investment in healthcare increases more people are getting aware of cancer disease and undergo advanced technology-based cancer treatment.
Continuously increasing healthcare expenditure help the end user to install the latest technology-based radiotherapy systems to improve efficiency, accuracy, and number of successful radiotherapy cancer treatments.
- Lack of skilled and certified professionals
Radiotherapy is a type of complex procedure, operated by highly advanced radiotherapy products which deliver radiation explorer to a targeted point of the patient body to destroy the cancer cells. The radiotherapy procedure requires highly skilled and certified professionals as in this procedure, healthcare professionals have to decide the dosages of radiation delivered to the patient's body with the help of treatment planning software. Healthcare professionals need to be aware of how to handle these software and therapy modalities. The requirement for skilled and certified professionals is a big restraint for the market. The demand for cancer treatment is increasing due to continuously increasing cases of cancer disease across the world but a lack of skilled and certified professionals hampering the growth of the market.
- In June 2023, Merit Medical Systems. acquired Bluegrass Vascular’s Surfacer Inside-Out Access Catheter System. This has helped the company to generate more revenues
- In June 2023, Sonablate Corp. was recognized as one of CEO View’s top 10 healthcare companies of the year 2023. This has helped the company to establish its presence in the europe radiotherapy market
- In November 2022, Terumo Europe NV announced that it welcomed the positive guidance released by the National Institute for Health and Care Excellence (NICE), mentioning that microwave ablation can be used provided standard arrangements are in place for clinical governance, consent, and audit. This is positive news as it broadens access to minimally invasive alternatives to surgery available to patients with symptomatic benign thyroid nodules
- In July 2022, EDAP TMS announced Focal One HIFU reimbursement raised to urology APC Level 6 under CMS Outpatient Prospective Payment System (OPPS) Proposed Rule for CY23. This has helped the company to establish its Europe presence
- In July 2021, Bioventus LLC. and Misonix announced definitive agreement for Bioventus to acquire Misonix. This has helped the company to strengthen its product portfolio
Europe Radiotherapy Market Scope
The radiotherapy market is segmented into five notable segments such as product & services, type, application, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product & Services
On the basis of product & services, the market is segmented into services, product, and software.
- External-Beam Radiation Therapy
- Internal Radiation Therapy
- Systemic Radiotherapy/ Radiopharmaceuticals
On the basis of type, the market is segmented into external-beam radiation therapy, internal radiation therapy, systemic radiotherapy/ radiopharmaceuticals, and others.
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Colorectal Cancer
- Liver Cancer
- Thyroid Cancer
- Brain Cancer
- Cervical Cancer
- Spine Cancer
On the basis of application, the market is segmented into breast cancer, lung cancer, prostate cancer, colorectal cancer, lymphoma, liver cancer, thyroid cancer, brain cancer, cervical cancer, spine cancer, and others.
- Radiation Therapy Centers
- Specialty Clinics
On the basis of end user, the market is segmented into hospitals, radiation therapy centers, specialty clinics, and others.
- Direct Tenders
- Third Party Distributors
On the basis of distribution channel, the market is segmented into direct tenders, third party distributors, and others.
Europe Radiotherapy Market Regional Analysis/Insights
The radiotherapy market is analyzed and market size insights and trends are provided by country, product & services, type, application, end user, and distribution channel as referenced above.
The countries covered in this market report are Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Sweden, and Rest of Europe.
Germany is expected to dominate the market due to the higher level of investments by various manufacturers and increasing demand for radiotherapy in the country.
The country section of the report also provides individual market-impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends, porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of regional brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Europe Radiotherapy Market Share Analysis
The radiotherapy market competitive landscape provides details of the competitor. Details included are company overview, company financials, revenue generated, market potential, new market initiatives, regional presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major market players operating in the radiotherapy market are Siemens Healthcare GmbH, Elekta, Accuray Incorporated, General Electric Company, IBA Worldwide, Koninklijke Philips N.V., Hitachi, Ltd. , CANON MEDICAL SYSTEMS CORPORATION, Nordion Inc. (A Subsidiary of Sotera Health), Mevion Medical Systems, Eckert & Ziegler BEBIG, VIEWRAY TECHNOLOGIES, INC. (“VIEWRAY”), Brainlab, ZEISS International, BEBIG Medical., SHINVA MEDICAL INSTRUMENT CO., LTD., LinaTech, Inc., and United Imaging Healthcare Co., Ltd., among others.